EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ultrasound Responsive Nanovaccine Armed with Engineered Cancer Cell Membrane and RNA to Prevent Foreseeable Metastasis

Wenqi Sun iD, Panpan Ji, Tian Zhou, Zhelong Li, Changyang Xing, Liang Zhang, Mengying Wei, Guodong Yang, Lijun Yuan

Advanced Science · 2023

DOI: 10.1002/advs.202301107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Wenqi Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Diagnostics, Tangdu Hospital, Fourth Military Medical University, Shaanxi, 710038, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer vaccine has been considered as a promising immunotherapy by inducing specific anti‐tumor immune response. Rational vaccination at suitable time to efficiently present tumor associated antigen will boost tumor immunity and is badly needed. Here, a poly (lactic‐ co ‐glycolic acid) (PLGA)‐based cancer vaccine of nanoscale is designed, in which engineered tumor cell membrane proteins, mRNAs, and sonosensitizer chlorin e6 (Ce6) are encapsulated at high efficiency. The nanosized vaccine can be efficiently delivered into antigen presentation cells (APCs) in lymph nodes after subcutaneous injection. In the APCs, the encapsulated cell membrane and RNA from engineered cells, which have disturbed splicing resembling the metastatic cells, provide neoantigens of metastatic cancer in advance. Moreover, the sonosensitizer Ce6 together with ultrasound irradiation promotes mRNA escape from endosome, and augments antigen presentation. Through 4T1 syngeneic mouse model, it has been proved that the proposed nanovaccine is efficient to elicit antitumor immunity and thus prevent cancer metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesNeoplasmsAnimalsMicePolylactic Acid-Polyglycolic Acid CopolymerDendritic CellsRNAAntigen PresentationCell MembraneAntigens, Neoplasm

Stichwörter der Autor:innen

alternative splicingantigen presentationcancer vaccinesonosensitizer

Substanzen

Polylactic Acid-Polyglycolic Acid CopolymerCancer VaccinesRNAAntigens, Neoplasm

Autor:innen und Institutionen

  • Department of Ultrasound Diagnostics, Tangdu Hospital, Fourth Military Medical University, Shaanxi, 710038, China.
  • The State Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Shaanxi, 710032, China.
  • Department of Digestive Surgery, Xijing Hospital, Fourth Military Medical University, Shaanxi, 710032, China.

ORCID-Profile: Wenqi Sun

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, W., Ji, P., Zhou, T., Li, Z., Xing, C., Zhang, L., Wei, M., Yang, G., & Yuan, L. (2023). Ultrasound Responsive Nanovaccine Armed with Engineered Cancer Cell Membrane and RNA to Prevent Foreseeable Metastasis. Advanced Science. https://doi.org/10.1002/advs.202301107

Vancouver

Sun W, Ji P, Zhou T, Li Z, Xing C, Zhang L, et al. Ultrasound Responsive Nanovaccine Armed with Engineered Cancer Cell Membrane and RNA to Prevent Foreseeable Metastasis. Advanced Science. 2023. doi:10.1002/advs.202301107

BibTeX
@article{Sun2023,
  author = {Sun, Wenqi and Ji, Panpan and Zhou, Tian and Li, Zhelong and Xing, Changyang and Zhang, Liang and Wei, Mengying and Yang, Guodong and Yuan, Lijun},
  title = {Ultrasound Responsive Nanovaccine Armed with Engineered Cancer Cell Membrane and RNA to Prevent Foreseeable Metastasis},
  journal = {Advanced Science},
  year = {2023},
  doi = {10.1002/advs.202301107}
}
Kostenlos starten →